CHTR vs TRDA · P/E 11, rev $55.09B vs P/E 12, rev $210.8M
Charter Communications Inc (CHTR) versus Entrada Therapeutics Inc (TRDA) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Entrada Therapeutics Inc (TRDA) is a biotechnology company listed on US.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported TRDA revenue for 2024-12-31 was $210.8M. Net income was $65.6M. Revenue was up 63.4% from 2023-12-31 to 2024-12-31. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. TRDA currently screens at market cap $274.4M and trailing P/E 12.5.
Not investment advice. Open the CHTR and TRDA stock pages for the full models.
Not investment advice.